Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.420
-0.090 (-5.96%)
At close: Jun 23, 2026, 4:00 PM EDT
1.450
+0.030 (2.11%)
After-hours: Jun 23, 2026, 7:59 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.08 million as of June 23, 2026. Its market cap has decreased by -25.44% in one year.
Market Cap
6.08M
Enterprise Value
-3.18M
1-Year Change
-25.44%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.08M, a decrease of -89.39%. That is a compound annual growth rate of -36.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.08M | 3.91% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.99M |
| Ernexa Therapeutics | 6.87M |
| Xenetic Biosciences | 6.74M |
| Can-Fite BioPharma | 6.55M |
| Silo Pharma | 6.52M |
| NextCure | 6.32M |
| Purple Biotech | 6.27M |
| CNS Pharmaceuticals | 6.26M |